Announced today the closing of a substantial funding round pharmacy rx.

Avinger closes significant financing circular to initiate clinical trial on peripheral atherectomy catheter Avinger, Inc pharmacy rx . Maker of therapeutic products incorporating intravascular pioneer and imaging of the lumivascular method of treating vascular disease, announced today the closing of a substantial funding round. Both new in addition to existing traders participated in the funding. We have been very delighted with the outcome of the latest capital raise, to aid what we anticipate to become a very successful scientific trial of Pantheris, the first-ever peripheral atherectomy catheter that also includes intravascular imaging technology using Optical Coherence Tomography , stated Kenneth Novack, Chairman of Avinger's Board of Directors.